For example, population‐based studies reported that a low plasma adiponectin level was associated with an increased risk for gastric cancer (GAC), pancreatic cancer (PAC), and esophageal cancer (ESC).5, 6, 7. Here, ADIPOQ is linked to gastric cancer.